Predicting the progression to super-refractory status epilepticus: A machine-learning study.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 12 2022
Historique:
received: 23 07 2022
revised: 20 10 2022
accepted: 24 10 2022
pubmed: 5 11 2022
medline: 1 12 2022
entrez: 4 11 2022
Statut: ppublish

Résumé

Super-refractory status epilepticus (SRSE) is a status epilepticus (SE) that continues or recurs ≥24 h after the onset of anesthesia. We aimed to identify the predictors of progression to SRSE and the risk of 30-day mortality in patients with SRSE by using a machine learning technique. We reviewed consecutive SE episodes in patients aged ≥14 years at Baggiovara Civil Hospital (Modena, Italy) from 2013 to 2021. A classification and regression tree analysis was performed to develop a predictive model of progression to SRSE in SE patients. In SRSE patients, a multivariate analysis was conducted to identify predictors of 30-day mortality. We included 705 patients, 16% of whom (113/705) progressed to SRSE. Acute symptomatic hypoxic etiology and age ≤ 68.5 years predicted the highest risk (87.1%) of progression to SRSE. Etiology other than acute symptomatic hypoxic and absence of NCSE predicted the lowest risk (3.6%) of progression to SRSE. The predictive model was accurate in 96.1% of patients not evolving to SRSE and in 48.7% of those evolving to SRSE. Among patients with SRSE, 46.9% (53/113) died within 30 days compared to 25.2% (149/592) of patients without SRSE (p < 0.001). Among patients with SRSE, older age was associated with increased 30-day mortality (odds ratio 1.075; 95% confidence interval: 1.031-1.112; p = 0.001). Acute symptomatic hypoxic etiology and younger age are major predictors of progression to SRSE. In patients with SRSE, older age is associated with increased risk of short-term mortality.

Identifiants

pubmed: 36332322
pii: S0022-510X(22)00343-4
doi: 10.1016/j.jns.2022.120481
pii:
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

120481

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Francesco Brigo (F)

Hospital of Merano-Meran (SABES-ASDAA), Department of Neurology, Merano-Meran, Italy. Electronic address: dr.francescobrigo@gmail.com.

Gianni Turcato (G)

Hospital of Santorso (AULSS-7), Department of Internal Medicine, Santorso, Italy.

Simona Lattanzi (S)

Marche Polytechnic University, Neurological Clinic, Department of Experimental and Clinical Medicine, Ancona, Italy.

Niccolò Orlandi (N)

Azienda Ospedaliera-Universitaria di Modena, Neurology Department, Modena, Italy; University of Modena and Reggio-Emilia, Department of Biomedical, Metabolic, and Neural Sciences, Modena and Reggio-Emilia, Italy.

Giulia Turchi (G)

Azienda Ospedaliera-Universitaria di Modena, Neurology Department, Modena, Italy.

Arian Zaboli (A)

Hospital of Merano-Meran (SABES-ASDAA), Department of Emergency Medicine, Merano-Meran, Italy.

Giada Giovannini (G)

Azienda Ospedaliera-Universitaria di Modena, Neurology Department, Modena, Italy; University of Modena and Reggio-Emilia, PhD Programm in Clinical and Experimental Medicine,Modena, Italy.

Stefano Meletti (S)

Azienda Ospedaliera-Universitaria di Modena, Neurology Department, Modena, Italy; University of Modena and Reggio-Emilia, Department of Biomedical, Metabolic, and Neural Sciences, Modena and Reggio-Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH